Healthcare Weekly Jamaica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Weekly Jamaica.

Press releases published on June 11, 2026

Jun. 11, 2026

C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population

Indeterminate GlobeNewswire

Jun. 11, 2026

Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Verano Completes 1-for-5 Reverse Stock Split, Advancing the Company’s Path Towards Prospective U.S. Stock Exchange Listing

Indeterminate GlobeNewswire

Jun. 11, 2026

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy

Indeterminate GlobeNewswire

Jun. 11, 2026

Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms

Indeterminate GlobeNewswire

Jun. 11, 2026

Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology

Indeterminate GlobeNewswire

Jun. 11, 2026

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia

Indeterminate GlobeNewswire

Jun. 11, 2026

Pharvaris Announces Annual General Meeting of Shareholders

Indeterminate GlobeNewswire

Jun. 11, 2026

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying Approach for Parkinson's Disease

Indeterminate GlobeNewswire

Jun. 11, 2026

Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline

Indeterminate GlobeNewswire

Jun. 11, 2026

Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Indeterminate GlobeNewswire

Jun. 11, 2026

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress

Indeterminate GlobeNewswire

Jun. 11, 2026

Cellectis présente les résultats finaux de phase 1 pour lasmé-cel et des résultats préliminaires pour éti-cel au congrès de l’EHA 2026

Indeterminate GlobeNewswire

Jun. 11, 2026

Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia

Indeterminate GlobeNewswire

Jun. 11, 2026

CARPL.ai Partners with Enlitic to Accelerate AI Validation for Imaging Customers

Indeterminate GlobeNewswire

Jun. 11, 2026

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 11, 2026

Tilray Medical Deutschland bringt ARX™ auf den Markt, eine neue Premium-Marke für medizinisches Cannabis aus deutschem Anbau

Indeterminate GlobeNewswire

Jun. 11, 2026

Tilray Medical Allemagne lance ARX™, une nouvelle marque de cannabis médicinal haut de gamme cultivé en Allemagne

Indeterminate GlobeNewswire